Targeting p300 HAT Activity as a Novel Anticancer Strategy

Starts:
2:00 pm on Wednesday, April 10, 2013
Ends:
3:20 pm on Wednesday, April 10, 2013
Location:
R-115
Rhoda M. Alani, M.D., Herbert Mescon Professor and Chair, Department of Dermatology, Boston University School of Medicine; Dermatologist-in-Chief, Boston Medical Center, will present her seminar "Targeting p300 HAT Activity as a Novel Anticancer Strategy."